ENHANCED HA
LIVE

Serial Number

99226554

Owner

RegenSkin LLC

Attorney

Lindsay Heather Kaplan

First Use Date

Aug 19, 2024

Filing Date

Jun 10, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ENHANCED HA Trademark

Serial Number: 99226554

ENHANCED HA is a trademark filed by RegenSkin LLC on June 10, 2025. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

RegenSkin LLC (3 trademarks)

95 Greene St.
Jersey City, NJ 07302

Entity Type: 16

Trademark Details

Filing Date

June 10, 2025

Registration Date

Not Registered

First Use Anywhere

August 19, 2024

First Use in Commerce

August 19, 2024

Goods & Services

Collagen preparations for cosmetics purposes; Cosmetic preparations; Non-medicated skin care preparations; Cosmetic ingredient complex composed of hyaluronic acid, silk proteins, chitosan, platelet rich plasma, platelet rich fibrin, bone marrow concentrate, collagen, or any combination thereof, sold as an integral component of non-medicated skincare preparations; all of the foregoing containing hyaluronic acid, or used in association with hyaluronic acid, or used before, during or after a hyaluronic acid procedure.

Medical devices, namely, tubing and bag assembly set and other similar or related devices, which process and treat human platelets with clinical medical reagents for the purpose of enabling the refrigerated storage of human platelets for blood groups for use in blood transfusions; Blood drawing apparatus; Blood collection needles; Filters for blood and blood components for medical purposes; Apparatus for taking blood; Blood containers for medical purposes; Blood component separation apparatus for medical purposes; Blood collection bags for veterinary purposes; Blood storage bags for medical purposes; Blood tubing sets for medical purposes; Blood collection bags for medical purposes; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical syringes; Hypodermic syringes; all of the foregoing containing hyaluronic acid, or used in association with hyaluronic acid, or used before, during or after a hyaluronic acid procedure.

Solutions for medical and clinical use in storing and treating cells, blood and blood components; Reagents for blood grouping for medical purposes; Hyaluronic acid for pharmaceutical purposes; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin care; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for use in regenerative medicine, aesthetic medicine, and dermatology; Pharmaceutical preparations for cellular therapy for the treatment of damaged skin or tissue; Chemical preparations for pharmaceutical or medical purposes, namely, for the preparation of autologous biological products; Biologics in the nature of cells for medical use; Biologics in the nature of pharmaceutical preparations for the treatment of damaged skin or tissue; Biologics in the nature of cells for the treatment of damaged skin or tissue; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Reagents for medical use; Biological reagents for medical purposes; Anticoagulants; all of the foregoing containing hyaluronic acid, or used in association with hyaluronic acid, or used before, during or after a hyaluronic acid procedure.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 23, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 23, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 23, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 27, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 4, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 4, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 4, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2025 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Jun 10, 2025 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 10, 2025 PARI
APPLICATION FILING RECEIPT MAILED
Jun 10, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2025 NWOS
NEW APPLICATION ENTERED
Jun 10, 2025 NWAP